185 related articles for article (PubMed ID: 32523894)
1. Shiga Toxin-Bearing Microvesicles Exert a Cytotoxic Effect on Recipient Cells Only When the Cells Express the Toxin Receptor.
Johansson K; Willysson A; Kristoffersson AC; Tontanahal A; Gillet D; Ståhl AL; Karpman D
Front Cell Infect Microbiol; 2020; 10():212. PubMed ID: 32523894
[TBL] [Abstract][Full Text] [Related]
2. Microvesicle Involvement in Shiga Toxin-Associated Infection.
Villysson A; Tontanahal A; Karpman D
Toxins (Basel); 2017 Nov; 9(11):. PubMed ID: 29156596
[TBL] [Abstract][Full Text] [Related]
3. Human Gb3/CD77 synthase produces P1 glycotope-capped N-glycans, which mediate Shiga toxin 1 but not Shiga toxin 2 cell entry.
Szymczak-Kulus K; Weidler S; Bereznicka A; Mikolajczyk K; Kaczmarek R; Bednarz B; Zhang T; Urbaniak A; Olczak M; Park EY; Majorczyk E; Kapczynska K; Lukasiewicz J; Wuhrer M; Unverzagt C; Czerwinski M
J Biol Chem; 2021; 296():100299. PubMed ID: 33460651
[TBL] [Abstract][Full Text] [Related]
4. Blood group P1 antigen-bearing glycoproteins are functional but less efficient receptors of Shiga toxin than conventional glycolipid-based receptors.
Morimoto K; Suzuki N; Tanida I; Kakuta S; Furuta Y; Uchiyama Y; Hanada K; Suzuki Y; Yamaji T
J Biol Chem; 2020 Jul; 295(28):9490-9501. PubMed ID: 32409578
[TBL] [Abstract][Full Text] [Related]
5. Shiga Toxin Uptake and Sequestration in Extracellular Vesicles Is Mediated by Its B-Subunit.
Willysson A; Ståhl AL; Gillet D; Barbier J; Cintrat JC; Chambon V; Billet A; Johannes L; Karpman D
Toxins (Basel); 2020 Jul; 12(7):. PubMed ID: 32664382
[TBL] [Abstract][Full Text] [Related]
6. Shiga toxin signals via ATP and its effect is blocked by purinergic receptor antagonism.
Johansson KE; Ståhl AL; Arvidsson I; Loos S; Tontanahal A; Rebetz J; Chromek M; Kristoffersson AC; Johannes L; Karpman D
Sci Rep; 2019 Oct; 9(1):14362. PubMed ID: 31591425
[TBL] [Abstract][Full Text] [Related]
7. Verotoxin Receptor-Based Pathology and Therapies.
Lingwood C
Front Cell Infect Microbiol; 2020; 10():123. PubMed ID: 32296648
[TBL] [Abstract][Full Text] [Related]
8. Tumor necrosis factor alpha increases human cerebral endothelial cell Gb3 and sensitivity to Shiga toxin.
Eisenhauer PB; Chaturvedi P; Fine RE; Ritchie AJ; Pober JS; Cleary TG; Newburg DS
Infect Immun; 2001 Mar; 69(3):1889-94. PubMed ID: 11179369
[TBL] [Abstract][Full Text] [Related]
9. Shiga toxin-induced complement-mediated hemolysis and release of complement-coated red blood cell-derived microvesicles in hemolytic uremic syndrome.
Arvidsson I; Ståhl AL; Hedström MM; Kristoffersson AC; Rylander C; Westman JS; Storry JR; Olsson ML; Karpman D
J Immunol; 2015 Mar; 194(5):2309-18. PubMed ID: 25637016
[TBL] [Abstract][Full Text] [Related]
10. Environmental Cues Modulate Microglial Cell Behavior Upon Shiga Toxin 2 From Enterohemorrhagic
Berdasco C; Duhalde Vega M; Rosato-Siri MV; Goldstein J
Front Cell Infect Microbiol; 2019; 9():442. PubMed ID: 31970091
[TBL] [Abstract][Full Text] [Related]
11. Eliglustat prevents Shiga toxin 2 cytotoxic effects in human renal tubular epithelial cells.
Sánchez DS; Fischer Sigel LK; Balestracci A; Ibarra C; Amaral MM; Silberstein C
Pediatr Res; 2022 Apr; 91(5):1121-1129. PubMed ID: 34155339
[TBL] [Abstract][Full Text] [Related]
12. Macropinocytosis in Shiga toxin 1 uptake by human intestinal epithelial cells and transcellular transcytosis.
Malyukova I; Murray KF; Zhu C; Boedeker E; Kane A; Patterson K; Peterson JR; Donowitz M; Kovbasnjuk O
Am J Physiol Gastrointest Liver Physiol; 2009 Jan; 296(1):G78-92. PubMed ID: 18974311
[TBL] [Abstract][Full Text] [Related]
13. Gb3-Coated Bovine Milk Exosomes as a Practical Neutralizer for Shiga Toxin.
Lu M; Zhu Y; Li D; Zhou Z; Lin H; Hong H; Shi J; Wu Z
ACS Appl Bio Mater; 2023 Dec; 6(12):5798-5808. PubMed ID: 37988327
[TBL] [Abstract][Full Text] [Related]
14. Endothelial heterogeneity in Shiga toxin receptors and responses.
Obrig TG; Louise CB; Lingwood CA; Boyd B; Barley-Maloney L; Daniel TO
J Biol Chem; 1993 Jul; 268(21):15484-8. PubMed ID: 8340376
[TBL] [Abstract][Full Text] [Related]
15. Gene expression profile and injury sites in mice treated with Shiga toxin 2 and lipopolysaccharide as a Shiga toxin-associated hemolytic uremic syndrome model.
Kume Y; Go H; Maeda R; Suyama K; Mori T; Kawasaki Y; Hashimoto K; Hosoya M
Physiol Genomics; 2022 May; 54(5):153-165. PubMed ID: 35384732
[TBL] [Abstract][Full Text] [Related]
16. Pathogenesis of Shigella diarrhea: XVII. A mammalian cell membrane glycolipid, Gb3, is required but not sufficient to confer sensitivity to Shiga toxin.
Jacewicz MS; Mobassaleh M; Gross SK; Balasubramanian KA; Daniel PF; Raghavan S; McCluer RH; Keusch GT
J Infect Dis; 1994 Mar; 169(3):538-46. PubMed ID: 8158025
[TBL] [Abstract][Full Text] [Related]
17. The ether lipid precursor hexadecylglycerol protects against Shiga toxins.
Bergan J; Skotland T; Lingelem AB; Simm R; Spilsberg B; Lindbäck T; Sylvänne T; Simolin H; Ekroos K; Sandvig K
Cell Mol Life Sci; 2014 Nov; 71(21):4285-300. PubMed ID: 24740796
[TBL] [Abstract][Full Text] [Related]
18. Rapid method to detect shiga toxin and shiga-like toxin I based on binding to globotriosyl ceramide (Gb3), their natural receptor.
Ashkenazi S; Cleary TG
J Clin Microbiol; 1989 Jun; 27(6):1145-50. PubMed ID: 2666433
[TBL] [Abstract][Full Text] [Related]
19. Globotriaosylceramide (Gb3) content in HeLa cells is correlated to Shiga toxin-induced cytotoxicity and Gb3 synthase expression.
Shin IS; Ishii S; Shin JS; Sung KI; Park BS; Jang HY; Kim BW
BMB Rep; 2009 May; 42(5):310-4. PubMed ID: 19470247
[TBL] [Abstract][Full Text] [Related]
20. Isolation and Characterization of Shiga Toxin-Associated Microvesicles.
Willysson A; Ståhl AL; Karpman D
Methods Mol Biol; 2021; 2291():207-228. PubMed ID: 33704755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
